Although two previous meta-analyses have reported the potential of Ki-67/MKI67 as a predictive biomarker in patients with GC 18, 19, studies based on more cases and stronger evidence are still needed to corroborate the prognostic and clinicopathological role of Ki-67/MKI67 for GC patients. The gene discussed is MKI67; the disease is gastric cancer.